NCT00570726View on ClinicalTrials.gov

Treatment of Failing Blebs With Ranibizumab

PHASE1CompletedINTERVENTIONAL

Enrollment

6

Participants

Timeline

Start Date

June 30, 2000

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions

Glaucoma, Open-AngleFailing Bleb Following Trabeculectomy

Interventions

DRUG

Ranibizumab (Lucentis)

Trial Locations (1)

10003

Glaucoma Associates of New York, New York

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

The New York Eye & Ear Infirmary

OTHER